Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. - Wikidata - awgldk - TriplyDB

Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

http://www.wikidata.org/entity/Q37415942

about

Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants?Clinical Implications of Basic Science Discoveries: Microchimerism Finds a Major Role in Reproductive Success; but Does It Also Contribute to Transplant Success?Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy Umbilical cord blood transplantation: the first 25 years and beyond.Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.Stem cell microchimerism and tolerance to non-inherited maternal antigens.The pendulum swings: Tolerance versus priming to NIMA.How I treat: the selection and acquisition of unrelated cord blood grafts.Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation.Microchimerism in cord blood: mother as anticancer drug.HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection.HLA-targeted cell sorting of microchimeric cells opens the way to phenotypical and functional characterization A perspective on the selection of unrelated donors and cord blood units for transplantation Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.Bidirectional alloreactivity: A proposed microchimerism-based solution to the NIMA paradox.Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus.The Role of HLA in Cord Blood Transplantation.Extensive haplotype diversity in African American mothers and their cord blood units.Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.Genetics of graft-versus-host disease: the major histocompatibility complex.Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société França Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model.Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance.Clinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in Korea.The great debate: haploidentical or cord blood transplant.On the future of HLA.Umbilical cord blood immunology: relevance to stem cell transplantation.Emerging concepts in haematopoietic cell transplantation.Using HLA typing to support patients with cancer.Cord blood transplant for acute myeloid leukaemia.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Impact of HLA in cord blood transplantation outcomes.Donor-derived exosomes: the trick behind the semidirect pathway of allorecognition.Graft predominance after double umbilical cord blood transplantation: a review.Consideration of noninherited maternal Ags as permissible HLA mismatches in cord blood donor selection.Identification of a novel HLA allele, HLA-B*53:39, in a Guadaloupean individual.Human Umbilical Cord Blood Cell Transplantation in Neuroregenerative Strategies

P2860

Q26770210-E1CE33FD-80D9-4092-8CDD-1765DE25E3F0 Q26809940-AF183E29-2751-4E66-98E3-9620C7E236CA Q30557220-334D1668-77A5-41A7-8E56-3A4522692638 Q34344669-3AF3C166-4090-44F4-9467-2E3B354B65C9 Q34352679-D5F29AD4-7183-42AA-A482-4BE88EECC033 Q34369195-2E8E6ED1-0F6C-4DA3-8572-E0BF55CCABA6 Q34558114-2FE1AA1F-17A8-4376-8BBE-60D0360B9198 Q34707580-2D782FCB-303F-4C3F-8A9F-560FD64C7A60 Q34749292-DE7A2C28-4581-4284-BDAB-A89023F925B3 Q35786957-B46E4D42-5008-4A1E-BACA-13FFC3B9C81F Q35787149-3F81A335-E909-49A3-8154-CD3B6BA69753 Q35794126-144058A2-145F-4071-B9C4-5C37BB84E7CC Q35877017-821C055C-61D4-47D3-B2F9-23C4CBA80972 Q36100445-BF50E9ED-5923-4F29-97B8-32D613FCD610 Q36107961-3003BFCC-4809-468D-9A75-C42F2CFEF007 Q36235319-EF22E8ED-7073-4E86-A657-E4F94D1732C8 Q36268546-C63CE6B4-0601-4C9E-9C9D-BB272B7048B6 Q36336608-98E8CA3B-DD67-47A8-8098-788FE5F5E83F Q36728749-1732D830-97CD-4DE2-8B47-FEFD92CA47A7 Q36745209-391BAA59-DD7D-4A42-8AB7-D19505D06FC2 Q36746512-77DF0FAE-64C5-43A3-9D51-DB67F5A3F007 Q36766250-1D8ABA54-EA7E-4151-9332-95555644E768 Q36967170-E58F7C47-501F-4FDA-80F1-9A5EBFCC2919 Q37174254-D486C9ED-A93E-45D2-9406-EC71874B0A4C Q37396289-DDAB6BF0-1F5F-496A-9A46-7E919FF8CEC2 Q37626249-8FFC5C0C-BFB4-4616-8158-4D3E9445B7B1 Q37725142-61FA3494-4322-4C4C-8E32-344FC9AC7EFC Q37806066-4A78DC61-1B17-4266-9FB7-D194C9759578 Q37935058-23353DDD-E425-424D-98B3-782B1522A51F Q37963798-F709091A-68D9-4D37-9C47-BDA34251CBD1 Q38013047-E2E50406-4691-4C22-826D-79D8C5532BAE Q38287616-236D0991-64FE-4909-8CB9-6AC20BCCB337 Q38696346-275DB38B-B928-407F-82BF-9979CE389DEC Q38747929-BAA88AF8-5287-4595-A180-DDE42C6FCFC8 Q38802750-90C0CE2F-44DF-40DD-9DFA-754EE4A31985 Q39023591-A86C2FCC-E3D2-4EB6-B543-1FACFEA71C14 Q39368481-EDB9009E-5B56-4DB6-A2CF-FF31AD1E774A Q40818958-41EF53B2-B72D-48A5-B671-CA4378A6CD0B Q41253082-A6E527ED-9996-4983-A1A0-489A943D311A Q41688586-5DC97F98-1543-4F5F-99A7-514E0C46CAAE

P2860

Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

http://www.wikidata.org/entity/Q37415942

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Reexposure of cord blood to no ...... in hematological malignancies.

@en

Reexposure of cord blood to no ...... in hematological malignancies.

@nl

type

label

Reexposure of cord blood to no ...... in hematological malignancies.

@en

Reexposure of cord blood to no ...... in hematological malignancies.

@nl

prefLabel

Reexposure of cord blood to no ...... in hematological malignancies.

@en

Reexposure of cord blood to no ...... in hematological malignancies.

@nl

P1433

Q37415942-B9C76492-3B70-4CB4-A5D3-284814D0B462

P1476

Q37415942-843012C5-B6FA-4A65-B347-DC5881FCB6C1

P2093

Q37415942-1CAB16FC-8185-4076-9581-5E391535D025

Q37415942-20F532D2-69AA-4B25-92B4-1F8466E2FA29

Q37415942-6A7A9E52-8273-4909-8EC1-48280E51845D

Q37415942-93A4AF0A-3738-4854-A051-C76F8EAA7A04

Q37415942-99C4621D-C962-4262-8F86-452E0F467ED0

Q37415942-E2BF56CE-CF90-402D-8391-10620043C640

P2860

Q37415942-0EDB6E9D-FD2D-4EA1-9C95-F02366067AF9

Q37415942-189D21D2-008F-4274-ADBE-F272D030B847

Q37415942-287C9B19-F3B4-4755-8120-FFDD7AD5EB8F

Q37415942-3B47CDC1-4573-44B0-BC80-FCE8AD216BAE

Q37415942-41C93C48-3F00-42A3-BF8F-394E33CF48D8

Q37415942-68C6CE5F-DB0B-4451-887C-F54B2F8DDBFA

Q37415942-6DD50541-5F40-46B0-9733-F29DB31D2237

Q37415942-71469BA4-2023-4809-B036-753CF7423ECD

Q37415942-84DB3AE4-F775-470C-807B-F987B7122C2B

Q37415942-9775C789-C070-4D2B-B4B2-78E1464381FC

P304

Q37415942-DA99588A-FDFA-4032-B5C1-E72F2AF52823

P31

Q37415942-0B771FE0-95E3-4D19-8293-880193BFACC9

P356

Q37415942-2FD67013-CD10-4B08-A113-134783229747

P407

Q37415942-7C73E610-2ACA-4BD3-9EF4-285EF1AB1ED5

P433

Q37415942-166971F9-CFBF-4753-A6D2-1A8FB1634416

P478

Q37415942-89A54DE7-E916-4AB9-9214-723583F4611F

P577

Q37415942-61E0C647-6A08-4E4D-98E8-8F494050EEE2

P5875

Q37415942-9D408E4A-968D-4682-A244-2E1C07591F7C

P698

Q37415942-366F901A-F142-421A-8248-EFA1B317A165

P921

Q37415942-8F3CF6E8-9E4B-4033-8DF3-200E388DB6B9

P932

Q37415942-15360172-7CE8-48A6-A602-7D26A4B8C753

P356

PNAS.0910310106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Reexposure of cord blood to no ...... in hematological malignancies.

@en

P2093

Andromachi Scaradavou

http://www.w3.org/2001/XMLSchema#string

Carmelita Carrier

http://www.w3.org/2001/XMLSchema#string

Carol Carpenter

http://www.w3.org/2001/XMLSchema#string

Cladd E Stevens

http://www.w3.org/2001/XMLSchema#string

Jacqueline Smits

http://www.w3.org/2001/XMLSchema#string

Jon J van Rood

http://www.w3.org/2001/XMLSchema#string

P2860

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

A lesson in tolerance--maternal instruction to fetal cells.

Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1.

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

The effect of noninherited maternal antigens in allogeneic transplantation.

Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members

Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance.

Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.

Placental blood-derived hematopoietic stem cells for unrelated bone marrow reconstitution.

P304

19952-19957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0910310106

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38078156

http://www.w3.org/2001/XMLSchema#string

P698

19901324

http://www.w3.org/2001/XMLSchema#string

P921

maternal health

P932

2775036

http://www.w3.org/2001/XMLSchema#string